Evidence map›Paper›PMID 38192728›Full record

ArticleResearch and practice in thrombosis and haemostasis2024

Platelets from patients with chronic inflammation have a phenotype of chronic IL-1β release.

Martin Berger, Hendrik Maqua, Katharina Lysaja, Sebastian Frederik Mause, Mathew S Hindle, Khalid Naseem, Edgar Dahl, Thimoteus Speer, Nikolaus Marx, Katharina Schütt

Open access · goldAbstract read
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Martin BergerDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Hendrik MaquaDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Katharina LysajaDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Sebastian Frederik MauseDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Mathew S HindleCentre for Biomedical Research, School of Health, Leeds Beckett University, Leeds, UK.
Khalid NaseemDiscovery and Translational Science Department, Leeds Institute of Cardiovascular & Metabolic Medicine, University of Leeds, Leeds, UK.
Edgar DahlRheinisch Westfälische Technische Hochschule Centralized Biomaterial Bank, University Hospital Aachen, Aachen, Germany.
Thimoteus SpeerDepartment of Internal Medicine IV, Goethe University Frankfurt, Frankfurt am Main, Germany.
Nikolaus MarxDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Katharina SchüttDepartment of Internal Medicine I, University Hospital Aachen, Aachen, Germany.
Universitätsklinikum Aachen · DEGoethe University Frankfurt · DELeeds Beckett University · GBUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic inflammation is a cardiovascular risk factor, and interleukin-1β (IL-1β) is central to the inflammatory host response. Platelets contain the NLRP3 inflammasome and are able to translate IL-1β messenger RNA (mRNA) and secrete mature IL-1β upon activation. However, the role of a chronic inflammatory environment in platelet IL-1β mRNA and protein content remains unclear. Objectives: The aim of the current study was to investigate intracellular platelet IL-1β and IL-1β mRNA in a chronic inflammatory state. Methods: Sixty-five patients with stable inflammation (ie, high-sensitivity C-reactive protein within predefined margins in 2 separate measurements) were stratified according to high-sensitivity C-reactive protein levels in low (0.0-0.9 mg/L), medium (1.0-2.9 mg/L), and high (3.0-9.9 mg/L) risk groups. Platelet reactivity as well as platelet IL-1β protein synthesis were studied. Results: The highest risk group was characterized by a distinct cardiovascular risk profile and approximately 20% higher platelet counts. While platelet reactivity was not different, a reduction in intracellular platelet IL-1β mRNA and IL-1β protein levels was observed in the highest risk group and was linked to decreased platelet size and granularity. This signature suggests a phenotype of chronic IL-1β secretion and could be experimentally phenocopied by stimulation of platelets from healthy volunteers with either TRAP-6 or collagen related peptide (CRP-XL). Conclusion: Our data suggest a phenotype of chronic IL-1β secretion by platelets in patients with chronic sterile inflammation.

Indexed as

caspase-1high sensitive C-reactive proteininflammationinterleukin-1betaplatelets

Identifiers

PMID38192728
PMCPMC10772383
OpenAlexW4388673223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.